Permanently Discontinued

APO-IRBESARTAN

APOTEX INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is APO-IRBESARTAN discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that APO-IRBESARTAN 75MG has been permanently discontinued (last updated January 4, 2019). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is APO-IRBESARTAN not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Possibly — same-ingredient product records found

StatusPermanently Discontinued

Same-ingredient products on file5 products

Affected strength75MG

Report last updated2019-01-04

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

IRBESARTAN

SANIS HEALTH INC

75MG · DIN 02372347

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

SANDOZ IRBESARTAN

SANDOZ CANADA INCORPORATED

75MG · DIN 02328461

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

AVAPRO

SANOFI-AVENTIS CANADA INC

150MG · DIN 02237924

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

PRO-IRBESARTAN

PRO DOC LIMITEE

150MG · DIN 02365200

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

PMS-IRBESARTAN

PHARMASCIENCE INC

300MG · DIN 02317087

Different strengthSame dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02386968

Strength

75MG

Dosage Form

TABLET

Route

ORAL

Active Ingredient

IRBESARTAN

See all IRBESARTAN products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2019-01-04

Permanently Discontinued

Business reasons

2018-11-09

Active Shortage

Disruption of the manufacture of the drug.

2018-08-21

Shortage Avoided

Disruption of the manufacture of the drug.

Other Products from APOTEX INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

24HR NASAL ALLERGY RELIEF

50MCG · DIN 02460513

ACETAMINOPHEN CAPLETS 325 MG

325MG · DIN 02362341

ACETAMINOPHEN CAPLETS 500 MG

500MG · DIN 02362368

ACETAMINOPHEN HEADACHE ULTRA RELIEF

DIN 02290901

ACETAMINOPHEN TABLETS USP 325 MG

325MG · DIN 02362422

ACETAMINOPHEN TABLETS USP 500 MG

500MG · DIN 02362244